title: Long-term biochemical results after high-dose-rate intensity modulated brachytherapy with external beam radiotherapy for high risk prostate cancer.
abstract: Biochemical control from series in which radical prostatectomy is performed for patients with unfavorable prostate cancer and/or low dose external beam radiation therapy are given remains suboptimal.The treatment regimen of HDR brachytherapy and external beam radiotherapy is a safe and very effective treatment for patients with high risk localized prostate cancer with excellent biochemical control and low toxicity.
authors.affiliation: Department of Radiation Oncology, Hospital Universitario Central de Asturias, Oviedo, Spain. pprada@telecable.es
authors.forename: Pedro J
authors.initials: PJ
authors.lastname: Prada
authors.forename: Lucia
authors.initials: L
authors.lastname: Mendez
authors.forename: José
authors.initials: J
authors.lastname: Fernández
authors.forename: Herminio
authors.initials: H
authors.lastname: González
authors.forename: Isabel
authors.initials: I
authors.lastname: Jiménez
authors.forename: Elisabeth
authors.initials: E
authors.lastname: Arrojo
mesh_terms: D000368:Aged; D001918:Brachytherapy / Q000009:adverse effects*; D005767:Gastrointestinal Diseases / Q000097:blood / Q000209:etiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000097:blood* / Q000532:radiotherapy*; D011832:Radiation Injuries / Q000097:blood / Q000209:etiology; D011879:Radiotherapy Dosage; D020266:Radiotherapy, Conformal; D050397:Radiotherapy, Intensity-Modulated / Q000009:adverse effects*; D014555:Urination Disorders / Q000097:blood / Q000209:etiology
chemical_list: D017430:Prostate-Specific Antigen